[HTML][HTML] Blue cone monochromatism: a phenotype and genotype assessment with evidence of progressive loss of cone function in older individuals
M Michaelides, S Johnson, MP Simunovic, K Bradshaw… - Eye, 2005 - nature.com
Eye, 2005•nature.com
Aim To perform a detailed clinical and psychophysical assessment of the members of three
British families affected with blue cone monochromatism (BCM), and to determine the
molecular basis of disease in these families. Methods Affected and unaffected members of
three families with BCM were examined clinically and underwent electrophysiological and
detailed psychophysical testing. Blood samples were taken for DNA extraction. The strategy
for molecular analysis was to amplify the coding regions of the long wavelength-sensitive (L) …
British families affected with blue cone monochromatism (BCM), and to determine the
molecular basis of disease in these families. Methods Affected and unaffected members of
three families with BCM were examined clinically and underwent electrophysiological and
detailed psychophysical testing. Blood samples were taken for DNA extraction. The strategy
for molecular analysis was to amplify the coding regions of the long wavelength-sensitive (L) …
Abstract
Aim
To perform a detailed clinical and psychophysical assessment of the members of three British families affected with blue cone monochromatism (BCM), and to determine the molecular basis of disease in these families.
Methods
Affected and unaffected members of three families with BCM were examined clinically and underwent electrophysiological and detailed psychophysical testing. Blood samples were taken for DNA extraction. The strategy for molecular analysis was to amplify the coding regions of the long wavelength-sensitive (L) and middle wavelength-sensitive (M) cone opsin genes and the upstream locus control region by polymerase chain reaction, and to examine these fragments for mutations by direct sequencing.
Results
We have confirmed the reported finding of protan-like D-15 arrangements of patients with BCM. In addition, we have demonstrated that the Mollon–Reffin (MR) Minimal test is a useful colour-discrimination test to aid in the diagnosis of BCM. Affected males were shown to fail the protan and deutan axes, but retained good discrimination on the tritan axis of the MR test, a compelling evidence for residual colour vision in BCM. This residual tritan discrimination was also readily detected with HRR plates. In two families, psychophysical testing demonstrated evidence for progression of disease. In two pedigrees, BCM could be linked to unequal crossovers within the opsin gene array that resulted in a single 5′-L/M-3′ hybrid gene, with an inactivating Cys203Arg mutation. The causative mutations were not identified in the third family.
Conclusions
The MR test is a useful method of detecting BCM across a wide range of age groups; residual tritan colour discrimination is clearly demonstrated and allows BCM to be distinguished from rod monochromatism. BCM is usually classified as a stationary cone dysfunction syndrome; however, two of our families show evidence of progression. This is the first report of progression associated with a genotype consisting of a single 5′-L/M-3′ hybrid gene carrying an inactivating mutation. We have confirmed that the Cys203Arg inactivating mutation is a common sequence change in blue cone monochromats.
nature.com
